EF Hutton Initiates Coverage On Kairos Pharma With Buy Rating, Announces Price Target of $9

Benzinga10/14 20:18

Kairos Pharma Analyst Ratings

Benzinga10/14 20:12

Top Premarket Decliners

MT Newswires10/02 19:54

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga09/27 00:31

Kairos Pharma to Partner With Genetic Sequencing Lab to Bolster Cancer Treatment

MT Newswires09/25 05:32

Kairos Pharma Shares Drop in First Trading Day

WSJ09/17 01:40